Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents.

What the trial testedas reported · 233 people · 2021

Not counted

+0.95+0.76 to +1.18

As reported

difference 0.95, 95% CI 0.76–1.18

the abstract, start to end

… means of NT-proBNP concentration was 0.95 (95% confidence interval [CI] …

← favours treatmentfavours comparator →

could be chance

Cardiac & vascular function

0.950.76–1.18

SGLT2 inhibitorsCardiac & vascular function

1 / 3

2021

2022

2023

2024

2025

2026

this papertrialcites it